Yao Dong
Department of Research and Development, Wecare Probiotics (Suzhou) Co., Ltd., Suzhou, China
- Papers in database
- 12
- Primary author
- 5 papers
- Years active
- 2023 – 2025
- Health outcomes studied
- 3
Health Outcomes Studied
Papers (12)
- 2025Primary authorProtective effects of Bifidobacterium longum subsp. longum BL21 against cyclophosphamide-induced reproductive dysfunction in zebrafish.10.1038/s41598-025-97721-w
- 2025Efficacy and Safety of <i>Lactobacillus acidophilus</i> LA85 in Preventing Antibiotic-Associated Diarrhea: A Randomized, Placebo-Controlled Study.10.1002/fsn3.70490
- 2025Primary authorThe impact of Bifidobacterium breve BBr60 (BBr60) on metabolic and gastrointestinal health in healthy adults: A combined in vitro metabolomic and randomized, double-blind, placebo-controlled study.10.1016/j.clnu.2025.07.004
- 2024Primary authorUtilization of diverse oligosaccharides for growth by Bifidobacterium and Lactobacillus species and their in vitro co-cultivation characteristics.10.1007/s10123-023-00446-x
- 2024Genome sequence and evaluation of safety and probiotic potential of <i>Lacticaseibacillus paracasei</i> LC86 and <i>Lacticaseibacillus casei</i> LC89.10.3389/fmicb.2024.1501502
- 2024Primary authorExtensive genomic characterization, pre-clinical probiotic evaluation, and safety analysis of Bifidobacterium longum subsp. longum BL21 isolated from infant feces.10.1016/j.micpath.2024.107100
- 2024Primary author<i>Lacticaseibacillus rhamnosus</i> LRa05 mediates dynamic regulation of intestinal microbiota in mice with low-dose DSS-induced chronic mild inflammation.10.3389/fmicb.2024.1483104
- 2024Gut Microbiome and Metabolome Alterations in Overweight or Obese Adult Population after Weight-Loss <i>Bifidobacterium breve</i> BBr60 Intervention: A Randomized Controlled Trial.10.3390/ijms252010871
- 2024Modulation of Serum Metabolic Profiles by <i>Bifidobacterium breve</i> BBr60 in Obesity: A Randomized Controlled Trial.10.3390/foods13223655
- 2023Changes in the gut microbiota composition of healthy young volunteers after administration of Lacticaseibacillus rhamnosus LRa05: A placebo-controlled study10.3389/fnut.2023.1105694
- 2023Sustained ameliorative effect of Lactobacillus acidophilus LA85 on dextran sulfate sodium-induced colitis in mice.10.1111/1750-3841.16723
- 2023Lacticaseibacillus rhamnosus Hao9 exerts antidiabetic effects by regulating gut microbiome, glucagon metabolism, and insulin levels in type 2 diabetic mice10.3389/fnut.2022.1081778